What are the potential risks of oncolytic virus therapy?

What are the potential risks of oncolytic virus therapy?

Common side effects associated with the currently approved oncolytic virus may include but are not limited to: chills, fatigue, flu-like symptoms, injection site pain, nausea, and fever.

Is oncolytic virus therapy effective?

Two new studies highlight efforts to expand the number of cancer types treated with oncolytic virus therapies as well as the methods of delivery. One of the studies found that an oncolytic virus delivered intravenously could cross the blood–brain barrier and enter brain tumors, killing tumor cells.

Can viruses be used to treat cancer?

Viruses engineered to kill cancer cells are already used to treat one form of skin cancer and are being widely tested as treatments for other cancers. A new study suggests that such viruses, known as oncolytic viruses, can be further enhanced to improve the body’s immune response against tumors.

Can bacteria cause tumors?

H. pylori is the first bacterium to be termed a definite cause of cancer in humans by the International Agency for Research on Cancer. Mutagenic bacterial metabolites are also suspected to increase risk for cancer.

Are oncolytic viruses safe?

Safety of oncolytic viruses remains a concern and most trials evaluate the safety aspect. The pooled risk ratio (RR) of severe adverse events (grade ≥3) was 1.44 (95\% CI: 1.17–1.78, p = 0.0006, I2 = 13\%) as shown in Figure 8a.

What is an oral oncolytic?

Oral oncolytic treatments are self-administered medications that can be conveniently dispensed at home. These treatments represent a new wave of intervention for cancer patients because patients do not need to be present in a healthcare facility to treat their disease.

How many oncolytic viruses are approved?

Globally, there are three approved oncolytic viruses, an adenovirus (H101) for the treatment of advanced head and neck cancer in China, Rigvir, an oncolytic reovirus approved for the treatment of advanced melanoma in Estonia, Latvia, Poland and Belarus, and most notably, talimogene laherparepvec (T-VEC), an oncolytic …

What are the two major bacteria that have been shown to be attracted to tumors?

Several bacterial genera have been shown to accumulate in tumor tissue. These bacteria can be divided in two groups based on their oxygen metabolism: obligate anaerobes (Bifidobacterium and Clostridium) and facultative anaerobes (Salmonella, Escherichia and Listeria) [22,42–45].